Genprex, Inc. (GNPX) stock
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.67−0.04 (-2.34%)
Close on Nov 19, 2026Market cap $1.37MP/E –Yield –
Genprex shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Genprex's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 1M, up 1063.9% from the year before. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +1063.9% |
| FY2024 | Dec 31, 2024 | 0M | +193.0% |
| FY2023 | Dec 31, 2023 | 0M | +14.1% |
| FY2022 | Dec 31, 2022 | 0M | +1.8% |
| FY2021 | Dec 31, 2021 | 0M | +32.6% |
| FY2020 | Dec 31, 2020 | 0M | +121.7% |
| FY2019 | Dec 31, 2019 | 0M | +16.4% |
| FY2018 | Dec 31, 2018 | 0M | +19.8% |
| FY2017 | Dec 31, 2017 | 0M | +6.1% |
| FY2016 | Dec 31, 2016 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 0M | +55.0% |
| Q1 FY2026 | Mar 31, 2026 | 7M | +9829.6% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +1658.8% |
| Q2 FY2025 | Jun 30, 2025 | 0M | -22.0% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +926.5% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +142.2% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +66.4% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +30.8% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +23.8% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +20.5% |
| Q2 FY2023 | Jun 30, 2023 | 0M | +8.5% |
| Q1 FY2023 | Mar 31, 2023 | 0M | +3.3% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +0.5% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +0.8% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +1.1% |
| Q1 FY2022 | Mar 31, 2022 | 0M | +5.1% |
| Q4 FY2021 | Dec 31, 2021 | 0M | +20.6% |
| Q3 FY2021 | Sep 30, 2021 | 0M | +21.9% |
| Q2 FY2021 | Jun 30, 2021 | 0M | +34.0% |
| Q1 FY2021 | Mar 31, 2021 | 0M | +62.9% |
| Q4 FY2020 | Dec 31, 2020 | 0M | +129.2% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +146.7% |
| Q2 FY2020 | Jun 30, 2020 | 0M | +126.3% |
| Q1 FY2020 | Mar 31, 2020 | 0M | +82.3% |
| Q4 FY2019 | Dec 31, 2019 | 0M | +14.5% |
| Q3 FY2019 | Sep 30, 2019 | 0M | +7.9% |
| Q2 FY2019 | Jun 30, 2019 | 0M | +15.6% |
| Q1 FY2019 | Mar 31, 2019 | 0M | +30.7% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +31.6% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +26.1% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +17.7% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +3.1% |
| Q4 FY2017 | Dec 31, 2017 | 0M | -0.2% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +6.9% |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?